Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
European Thyroid Journal|February 26, 2019
Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based StudyElse Marie Opsahl, Lars Andreas Akslen, Ellen Schlichting, et al.
International Journal of Cancer|June 4, 2020
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancerHedda von der Lippe Gythfeldt, Tonje Lien, Xavier Tekpli, et al.
Nature Communications|November 11, 2017
DNA methylation at enhancers identifies distinct breast cancer lineagesThomas Fleischer, Xavier Tekpli, Anthony Mathelier, et al.
Breast Cancer Research : BCR|November 16, 2017
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-upHege O Ohnstad, Elin Borgen, Ragnhild S Falk, et al.
Breast Cancer Research : BCR|September 20, 2005
Early detection of breast cancer based on gene-expression patterns in peripheral blood cellsPraveen Sharma, Narinder S Sahni, Robert Tibshirani, et al.
Cancer & Metabolism|June 29, 2016
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesTonje H Haukaas, Leslie R Euceda, Guro F Giskeødegård, et al.
BMC Cancer|November 20, 2014
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control studyMari Tinholt, Marte Kathrine Viken, Anders Erik Dahm, et al.
Molecular Oncology|December 21, 2010
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variablesSitharthan Kamalakaran, Vinay Varadan, Hege E Giercksky Russnes, et al.
Science Translational Medicine|July 2, 2010
Genomic architecture characterizes tumor progression paths and fate in breast cancer patientsHege G Russnes, Hans Kristian Moen Vollan, Ole Christian Lingjærde, et al.
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
Pageof 7